NHL (NON-HODGKIN LYMPHOMA)

Clinical trials for NHL (NON-HODGKIN LYMPHOMA) explained in plain language.

Never miss a new study

Get alerted when new NHL (NON-HODGKIN LYMPHOMA) trials appear

Sign up with your email to follow new studies for NHL (NON-HODGKIN LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New injection JL19001 enters early human testing for tough cancers

Disease control Not yet recruiting

This early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of blood cancer (B-cell non-Hodgkin lymphoma) that has come back or not responded to standard treatments. The main goal is to find a safe dose and check for side effects. About 1…

Matched conditions: NHL (NON-HODGKIN LYMPHOMA)

Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 10:58 UTC

NHL (NON-HODGKIN LYMPHOMA)

Get alerted when new NHL (NON-HODGKIN LYMPHOMA) trials appear

New injection JL19001 enters early human testing for tough cancers